PITRESSIN TANNATE Drug Patent Profile
Which patents cover Pitressin Tannate, and what generic alternatives are available?
Pitressin Tannate is a drug marketed by Parke Davis and is included in one NDA.
The generic ingredient in PITRESSIN TANNATE is vasopressin tannate. There is one drug master file entry for this compound. Additional details are available on the vasopressin tannate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PITRESSIN TANNATE?
- What are the global sales for PITRESSIN TANNATE?
- What is Average Wholesale Price for PITRESSIN TANNATE?
Summary for PITRESSIN TANNATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | PITRESSIN TANNATE at DailyMed |
US Patents and Regulatory Information for PITRESSIN TANNATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parke Davis | PITRESSIN TANNATE | vasopressin tannate | INJECTABLE;INJECTION | 003402-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
